[June 01, 2016]

North America In-Vitro Diagnostic Testing Services Market Trends and Forecasts 2016-2019 - Research and Markets

Research and Markets has announced the addition of the "In Vitro Diagnostic Testing Services Market Trends and Forecasts 2016-2019 - North America" report to their offering.

"In Vitro Diagnostic Testing Services - 2016 to 2019 North America Version" provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2015 Medicare Fee Payment Schedules to help sharpen your pricing. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions.

A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations.

Trends like:

- Changing demographics

- Emerging economies and global prosperity

- Biotechnology advances in genetics

- Pathogen evolution

- Climate change

- Globalization

- Automation

Exciting technical developments especially in the area of molecular diagnostics and pharmacogenomics hold the promise of dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.

Key Topics Covered:

1. Introduction and Market Definition

1.1 Introduction

1.2 Market Definition

1.3 Methodology

1.4 Medical Market and Clinical Laboratory Testing - Perspective

2. Market Overview

2.1 Market Participants

2.2 Market Segments

2.3 Industry Structure

2.4 Profiles of Key Companies

2.5 National and Regional Diversity

3. Market Trends

3.1 Factors Driving Growth

3.2 Factors Limiting Growth

3.3 Automation

3.4 Environment and Evolution

3.5 Diagnostic Technology Development

4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments

5. Country Market Sizes - North America

6. The Future of the Clinical Laboratory

Companies Mentioned - Sample List

- 14M Genomics

- 23Andme

- Abbott Laboratories

- Abcam

- Accelerate Diagnostics

- Achieving Dx

- Acibadem Labmed Laboratory

- Acm Medical Laboratory

- Act Genomics

- Adaptive Biotechnologies

- Adicon Clinical Laboratories, Inc.

- Aegis Sciences

- Agena Bioscience

- Alere Inc

- Altheadx

- Amarantus

- American Pathology Partners, Inc.

- Ariosa Diagnostics

- Arup Laboratories, Inc.

- Ascend Clinical, Llc

- Astrazeneca

- Atossa Genetics

- Aurora Diagnostics, Llc

- Avant-Amarantus-Theranostics

- Baylor College of Medicin

- Biofortuna

- Biomerieux

- Biomnis (France)

- Bio-Reference Laboratories, Inc.

For more information visit http://www.researchandmarkets.com/research/qb3vh7/in_vitro

View source version on businesswire.com: http://www.businesswire.com/news/home/20160601005813/en/

[ Back To TMCnet.com's Homepage ]